DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease

Brain

Volumn 136, Issue 10, 2013, Pages 3018-3027

  Sanchez Mut, Jose V ^a   Aso, Ester ^b   Panayotis, Nicolas ^c   Lott, Ira ^d   Dierssen, Mara ^e   Rabano, Alberto ^f   Urdinguio, Rocio G ^g   Fernandez, Agustin F ^g   Astudillo, Aurora ^g   Martin Subero, Jose I ^a   Balint, Balazs ^a   Fraga, Mario F ^g,h   Gomez, Antonio ^a   Gurnot, Cecile ⁱ   Roux, Jean Christophe ^c   Avila, Jesus ^j   Hensch, Takao K ⁱ   Ferrer, Isidre ^b   Esteller, Manel ^a,k,l  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c AIX MARSEILLE UNIVERSITY   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^f Instituto de Salud Carlos III   (Spain)

^g DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^h CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

ⁱ HARVARD UNIVERSITY   (United States)

^j UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^k UNIVERSITY OF BARCELONA   (Spain)

^l INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

more..

Author keywords

Alzheimer's disease; brain regions; DNA methylation; epigenetics

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA;

AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN MAPPING; BRAIN REGION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENE TARGETING; GENETIC ANALYSIS; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BRAIN; C57BL MOUSE; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; PROMOTER REGION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION; HUMANS; MICE; MICE, INBRED C57BL; PROMOTER REGIONS, GENETIC;

EID: 84884853033     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awt237     Document Type: Article

References (74)

1. Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP, et al. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex. J Alzheimers Dis 2012; 29: 571-88.
2. Bane TK, LeBlanc JF, Lee TD, Riggs AD. DNA affinity capture and protein profiling by SELDI-TOF mass spectrometry: effect of DNA methylation. Nucleic Acids Res 2002; 30: e69.
3. Bibikova M, Le J, Barnes B, Saedinia-Melnyk S, Zhou L, Shen R, et al. Genome-wide DNA methylation profiling using Infinium-assay. Epigenomics 2009; 1: 177-200.
4. Bock C, Tomazou EM, Brinkman AB, Müller F, Simmer F, Gu H, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol 2010; 28: 1106-14.
5. Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 1997; 19: 939-45.
6. Cao X, Yeo G, Muotri AR, Kuwabara T, Gage FH. Noncoding RNAs in the mammalian central nervous system. Annu Rev Neurosci 2006; 29: 77-103.
7. Cedar H, Bergman Y. Programming of DNA methylation patterns. Annu Rev Biochem 2012; 81: 97-117.
8. Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, et al. Functional annotation of the human brain methylome identifies tissuespecific epigenetic variation across brain and blood. Genome Biol 2012; 13: R43.
9. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature 2007; 447: 433-40.
10. Feng J, Zhou Y, Campbell SL, Le T, Li E, Sweatt JD, et al. Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons. Nat Neurosci 2010; 13: 423-30.
11. Franklin JL, Johnson EM Jr. Suppression of programmed neuronal death by sustained elevation of cytoplasmic calcium. Trends Neurosci 1992; 15: 501-8.
12. Guo H, Liu D, Gelbard H, Cheng T, Insalaco R, Fernandez JA, et al. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. Neuron 2004; 41: 563-72.
13. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA, et al. Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 2011; 14: 1345-51.
14. Grubb MS, Burrone J. Building and maintaining the axon initial segment. Curr Opin Neurobiol 2010; 20: 1-8.
15. Haass C, Kaether C, Thinakaran G, Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2012; 2: a006270.
16. Han H, Cortez CC, Yang X, Nichols PW, Jones PA, Liang G. DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter. Hum Mol Genet 2011; 20: 4299-310.
17. Harris RA, Wang T, Coarfa C, Nagarajan RP, Hong C, Downey SL, et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol 2010; 28: 1097-105.
18. Hedstrom KL, Ogawa Y, Rasband MN. AnkyrinG is required for maintenance of the axon initial segment and neuronal polarity. J Cell Biol 2008; 183: 635-40.
19. Hernandez DG, Nalls MA, Gibbs JR, Arepalli S, van der Brug M, Chong S. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet 2011; 20: 1164-72.
20. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 10: 679-92.
21. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010 26; 5: e8888.
22. Hund TJ, Koval OM, Li J, Wright PJ, Qian L, Snyder JS, et al. A b(IV)- spectrin/CaMKII signaling complex is essential for membrane excitability in mice. J Clin Invest 2010; 120: 3508-19.
23. Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, Hendrich BD, et al. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 2002; 10: 81-91.
24. Ito H, Usuda N, Atsuzawa K, Iwamoto I, Sudo K, Katoh-Semba R, et al. Phosphorylation by extracellular signal-regulated kinase of a multidomain adaptor protein, vinexin, at synapses. J Neurochem 2007; 100: 545-54.
25. Iwamoto K, Bundo M, Ueda J, Oldham MC, Ukai W, Hashimoto E, et al. Neurons show distinctive DNA methylation profile and higher interindividual variations compared with non-neurons. Genome Res 2011; 21: 688-96.
26. Jakovcevski M, Akbarian S. Epigenetic mechanisms in neurological disease. Nat Med 2012; 188: 1194-204.
27. Johnson MB, Kawasawa YI, Mason CE, Krsnik Z, Coppola G, BogdanovicD, et al. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 2009; 62: 494-509.
28. Kelly TK, Liu Y, Lay FD, Liang G, Berman BP, Jones PA. Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules. Genome Res 2012; 22: 2497-506.
29. Kress GJ, Dowling MJ, Eisenman LN, Mennerick S. Axonal sodium channel distribution shapes the depolarized action potential threshold of dentate granule neurons. Hippocampus 2010; 20: 558-71.
30. Khare T, Pai S, Koncevicius K, Pal M, Kriukiene E, Liutkeviciute Z, et al. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nat Struct Mol Biol 2012; 19: 1037-43.
31. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009; 324: 929-30.
32. Kulak MV, Cyr AR, Woodfield GW, Bogachek M, Spanheimer PM, Li T, et al. Transcriptional regulation of the GPX1 gene by TFAP2C and aberrant CpG methylation in human breast cancer. Oncogene 2012, in press. doi: 10.1038/onc.2012.400.
33. Ladd-Acosta C, Pevsner J, Sabunciyan S, Yolken RH, Webster MJ, Dinkins T, et al. DNA methylation signatures within the human brain. Am J Hum Genet 2007; 81: 1304-15.
34. Lee RS, Tamashiro KL, Aryee MJ, Murakami P, Seifuddin F, Herb B, et al. Adaptation of the CHARM DNA methylation platform for the rat genome reveals novel brain region-specific differences. Epigenetics 2011; 6: 1378-90.
35. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007; 445: 168-76.
36. Li X, Kumar Y, Zempel H, Mandelkow EM, Biernat J, Mandelkow E. Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration. EMBO J 2011; 30: 4825-37.
37. Lubin FD, Gupta S, Parrish RR, Grissom NM, Davis RL. Epigenetic mechanisms: critical contributors to long-term memory formation. Neuroscientist 2011; 17: 616-32.
38. Matsuyama M, Mizusaki H, Shimono A, Mukai T, Okumura K, Abe K, et al. A novel isoform of Vinexin, Vinexin gamma, regulates Sox9 gene expression through activation of MAPK cascade in mouse fetal gonad. Genes Cells 2005; 10: 421-34.
39. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron 2007; 53: 857-69.
40. Mitsumori T, Furuyashiki T, Momiyama T, Nishi A, Shuto T, Hayakawa T, et al. Thromboxane receptor activation enhances striatal dopamine release, leading to suppression of GABAergic transmission and enhanced sugar intake. Eur J Neurosci 2011; 34: 594-604.
41. Muja N, Blackman SC, Le Breton GC, DeVries GH. Identification and functional characterization of thromboxane A2 receptors in Schwann cells. J Neurochem 2001; 78: 446-56.
42. Münzel M, Globisch D, Brückl T, Wagner M, Welzmiller V, Michalakis S, et al. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angew Chem Int Ed Engl 2010; 49: 5375-7.
43. Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M, et al. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet 2012; 90: 260-72.
44. Obara Y, Kurose H, Nakahata N. Thromboxane A2 promotes interleukin- 6 biosynthesis mediated by an activation of cyclic AMP-response element-binding protein in 1321N1 human astrocytoma cells. Mol Pharmacol 2005; 68: 670-9.
45. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39: 409-21.
46. Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Yorimitsu M, Yokotani K. Centrally administered N-methyl-d-aspartate evokes the adrenal secretion of noradrenaline and adrenaline by brain thromboxane A2-mediated mechanisms in rats. Eur J Pharmacol 2008; 586: 145-50.
47. Oliveira AM, Hemstedt TJ, Bading H. Rescue of aging-associated decline in Dnmt3a2 expression restores cognitive abilities. Nat Neurosci 2012; 15: 1111-3.
48. Øster B, Linnet L, Christensen LL, Thorsen K, Ongen H, Dermitzakis ET, et al. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer. Int J Cancer 2013; 132: 2303-15.
49. Palmer LM, Stuart GJ. Site of action potential initiation in layer 5 pyramidal neurons. J Neurosci 2006; 26: 1854-63.
50. Panayotis N, Pratte M, Borges-Correia A, Ghata A, Villard L, Roux JC. Morphological and functional alterations in the substantia nigra pars compacta of the Mecp2-null mouse. Neurobiol Dis 2011a; 41: 385-97.
51. Panayotis N, Ghata A, Villard L, Roux JC. Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain. BMC Neurosci 2011b; 12: 47.
52. Paxinos G, Franklin KB. The mouse brain in stereotaxic coordinates. 2nd edn. San Diego: Academic Press; 2001.
53. Rao JS, Keleshian VL, Klein S, Rapoport SI. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients. Transl Psychiatry 2012; 2: e132.
54. Roux JC, Mamet J, Perrin D, Peyronnet J, Royer C, Cottet-Emard JM, et al. Neurochemical development of the brainstem catecholaminergic cell groups in rat. J Neural Transm 2003; 110: 51-65.
55. Rui W, Jin Z, Zhe G, Song H. The methylation of C/EBP b gene promoter and regulated by GATA-2 protein. Mol Biol Rep 2013; 40: 797-801.
56. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 2009; 37: e45.
57. Saura CA, Valero J. The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev Neurosci 2011; 22: 153-69.
58. Seidenfaden R, Desoeuvre A, Bosio A, Virard I, Cremer H. Glial conversion of SVZ-derived committed neuronal precursors after ectopic grafting into the adult brain. Mol Cell Neurosci 2006; 32: 187-98.
59. Shulman JM, Chipendo P, Chibnik LB, Aubin C, Tran D, Keenan BT, et al. Functional screening of Alzheimer pathology genome-wide association signals in Drosophila. Am J Hum Genet 2011; 88: 232-8.
60. Siegmund KD, Connor CM, Campan M, Long TI, Weisenberger DJ, Biniszkiewicz D, et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS One 2009; 2: e895.
61. Song CX, Szulwach KE, Fu Y, Dai Q, Yi C, Li X, et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat Biotechnol 2011; 29: 68-72.
62. Strathmann FG, Wang X, Mayer-Pröschel M. Identification of two novel glial-restricted cell populations in the embryonic telencephalon arising from unique origins. BMC Dev Biol 2007; 7: 33.
63. Szulwach KE, Li X, Li Y, Song CX, Wu H, Dai Q, et al. 5-hmC-mediated epigenetic dynamics during postnatal neurodevelopment and aging. Nat Neurosci 2011; 14: 1607-16.
64. Uemoto Y, Suzuki S, Terada N, Ohno N, Ohno S, Yamanaka S, et al. Specific role of the truncated betaIV-spectrin Sigma6 in sodium channel clustering at axon initial segments and nodes of ranvier. J Biol Chem 2007; 282: 6548-55.
65. Urdinguio RG, Sanchez-Mut JV, Esteller M. Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 2009; 8: 1056-72.
66. Wang SC, Oelze B, Schumacher A. Age-specific epigenetic drift in lateonset Alzheimer's disease. PLoS One 2008; 3: e2698.
67. Winkels R, Jedlicka P, Weise FK, Schultz C, Deller T, Schwarzacher SW, et al. Reduced excitability in the dentate gyrus network of betaIVspectrin mutant mice in vivo. Hippocampus 2009; 19: 677-86.
68. Wouters L, Göhlmann HW, Bijnens L, Kass SU, Molenberghs G, Lewi PJ. Graphical exploration of gene expression data: a comparative study of three multivariate methods. Biometrics 2003; 59: 1131-9.
69. Xiao J, Perry G, Troncoso J, Monteiro MJ. alpha-calcium- calmodulindependent kinase II is associated with paired helical filaments of Alzheimer's disease. J Neuropathol Exp Neurol 1996; 55: 954-63.
70. Xin Y, Chanrion B, Liu MM, Galfalvy H, Costa R, Ilievski B, et al. Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS One 2010; 5: e11357.
71. Yagami T, Takahara Y, Ishibashi C, Sakaguchi G, Itoh N, Ueda K, et al. Amyloid beta protein impairs motor function via thromboxane A2 in the rat striatum. Neurobiol Dis 2004; 16: 481-9.
72. Yang Y, Ogawa Y, Hedstrom KL, Rasband MN. betaIV spectrin is recruited to axon initial segments and nodes of Ranvier by ankyrinG. J Cell Biol 2007; 176: 509-19.
73. Yeo G, Holste D, Kreiman G, Burge CB. Variation in alternative splicing across human tissues. Genome Biol 2004; 5: R74.
74. Zhou D, Lambert S, Malen PL, Carpenter S, Boland LM, Bennett V. AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J Cell Biol 1998; 143: 1295-304.